RadNet, Inc. (RDNT) vs GeneDx Holdings Corp. (WGS)
RadNet, Inc. and GeneDx Holdings Corp. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $5.6B against $2.6B — 2.1× the size. GeneDx Holdings Corp. grew revenue faster over the last twelve months: 25.4% against 18.9%. RadNet, Inc. has the higher net margin (−0.93% vs −23.4%) and the higher return on invested capital (2.24% vs −27.7%). Across the 18 metrics below, RadNet, Inc. leads on 11 and GeneDx Holdings Corp. on 7.
Valuation
Profitability
| Metric | RDNT | WGS | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 11.53% | 69.37% | 50.89% |
| Operating margin | 3.12% | (20.34%) | (8.57%) |
| Net margin | (0.93%) | (23.40%) | (6.37%) |
| Free cash flow margin | 3.28% | (16.68%) | 0.00% |
| Return on equity | (1.64%) | (40.80%) | (2.92%) |
| Return on assets | (0.55%) | (22.50%) | (6.71%) |
| Return on invested capital | 2.24% | (27.70%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack